360 related articles for article (PubMed ID: 29592953)
1. Pharmacological activation of estrogen receptor beta augments innate immunity to suppress cancer metastasis.
Zhao L; Huang S; Mei S; Yang Z; Xu L; Zhou N; Yang Q; Shen Q; Wang W; Le X; Lau WB; Lau B; Wang X; Yi T; Zhao X; Wei Y; Warner M; Gustafsson JÅ; Zhou S
Proc Natl Acad Sci U S A; 2018 Apr; 115(16):E3673-E3681. PubMed ID: 29592953
[TBL] [Abstract][Full Text] [Related]
2. Selective Estrogen Receptor β Agonist LY500307 as a Novel Therapeutic Agent for Glioblastoma.
Sareddy GR; Li X; Liu J; Viswanadhapalli S; Garcia L; Gruslova A; Cavazos D; Garcia M; Strom AM; Gustafsson JA; Tekmal RR; Brenner A; Vadlamudi RK
Sci Rep; 2016 Apr; 6():24185. PubMed ID: 27126081
[TBL] [Abstract][Full Text] [Related]
3. Activation of ERβ hijacks the splicing machinery to trigger R-loop formation in triple-negative breast cancer.
Wang D; Tang M; Zhang P; Yang K; Huang L; Wu M; Shen Q; Yue J; Wang W; Gong Y; Warner M; Dai L; He H; Yang Z; Gustafsson JA; Zhou S
Proc Natl Acad Sci U S A; 2024 Mar; 121(13):e2306814121. PubMed ID: 38513102
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Targeting of Ovarian Cancer Stem Cells Using Estrogen Receptor Beta Agonist.
He Y; Alejo S; Venkata PP; Johnson JD; Loeffel I; Pratap UP; Zou Y; Lai Z; Tekmal RR; Kost ER; Sareddy GR
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806169
[TBL] [Abstract][Full Text] [Related]
5. Different Susceptibilities of Human Melanoma Cell Lines to G2/M Blockage and Cell Death Activation in Response to the Estrogen Receptor β agonist LY500307.
Pontecorvi G; Bellenghi M; Tait S; Tirelli V; Matarrese P; Mattia G; Carè A; Puglisi R
J Cancer; 2022; 13(5):1573-1587. PubMed ID: 35371312
[No Abstract] [Full Text] [Related]
6. Population pharmacokinetic/pharmacodynamic assessment of pharmacological effect of a selective estrogen receptor β agonist on total testosterone in healthy men.
Hu L; Jin Y; Li YG; Borel A
Clin Pharmacol Drug Dev; 2015 Jul; 4(4):305-14. PubMed ID: 27136911
[TBL] [Abstract][Full Text] [Related]
7. Fertility and developmental toxicity assessment in rats and rabbits with LY500307, a selective estrogen receptor beta (ERβ) agonist.
Hilbish KG; Breslin WJ; Johnson JT; Sloter ED
Birth Defects Res B Dev Reprod Toxicol; 2013 Oct; 98(5):400-15. PubMed ID: 24323950
[TBL] [Abstract][Full Text] [Related]
8. Activation of estrogen receptor beta signaling reduces stemness of glioma stem cells.
Sareddy GR; Pratap UP; Venkata PP; Zhou M; Alejo S; Viswanadhapalli S; Tekmal RR; Brenner AJ; Vadlamudi RK
Stem Cells; 2021 May; 39(5):536-550. PubMed ID: 33470499
[TBL] [Abstract][Full Text] [Related]
9. Metastasis Suppressors Regulate the Tumor Microenvironment by Blocking Recruitment of Prometastatic Tumor-Associated Macrophages.
Frankenberger C; Rabe D; Bainer R; Sankarasharma D; Chada K; Krausz T; Gilad Y; Becker L; Rosner MR
Cancer Res; 2015 Oct; 75(19):4063-73. PubMed ID: 26238785
[TBL] [Abstract][Full Text] [Related]
10. Targeting the primary tumor to generate CTL for the effective eradication of spontaneous metastases.
Yu P; Lee Y; Wang Y; Liu X; Auh S; Gajewski TF; Schreiber H; You Z; Kaynor C; Wang X; Fu YX
J Immunol; 2007 Aug; 179(3):1960-8. PubMed ID: 17641063
[TBL] [Abstract][Full Text] [Related]
11. The reversible P2Y12 inhibitor ticagrelor inhibits metastasis and improves survival in mouse models of cancer.
Gebremeskel S; LeVatte T; Liwski RS; Johnston B; Bezuhly M
Int J Cancer; 2015 Jan; 136(1):234-40. PubMed ID: 24798403
[TBL] [Abstract][Full Text] [Related]
12. Group 2 innate lymphoid cells promote TNBC lung metastasis via the IL-13-MDSC axis in a murine tumor model.
Zhao N; Zhu W; Wang J; Liu W; Kang L; Yu R; Liu B
Int Immunopharmacol; 2021 Oct; 99():107924. PubMed ID: 34217145
[TBL] [Abstract][Full Text] [Related]
13. Induction of interleukin-1β by mouse mammary tumor irradiation promotes triple negative breast cancer cells invasion and metastasis development.
Bouchard G; Therriault H; Bujold R; Saucier C; Paquette B
Int J Radiat Biol; 2017 May; 93(5):507-516. PubMed ID: 27935337
[TBL] [Abstract][Full Text] [Related]
14. Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer.
Takai K; Le A; Weaver VM; Werb Z
Oncotarget; 2016 Dec; 7(50):82889-82901. PubMed ID: 27756881
[TBL] [Abstract][Full Text] [Related]
15. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
16. Agonists and knockdown of estrogen receptor β differentially affect invasion of triple-negative breast cancer cells in vitro.
Schüler-Toprak S; Häring J; Inwald EC; Moehle C; Ortmann O; Treeck O
BMC Cancer; 2016 Dec; 16(1):951. PubMed ID: 28003019
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells.
Cotrim CZ; Fabris V; Doria ML; Lindberg K; Gustafsson JÅ; Amado F; Lanari C; Helguero LA
Oncogene; 2013 May; 32(19):2390-402. PubMed ID: 22751110
[TBL] [Abstract][Full Text] [Related]
18. IL-15 superagonist RLI has potent immunostimulatory properties on NK cells: implications for antimetastatic treatment.
Desbois M; Béal C; Charrier M; Besse B; Meurice G; Cagnard N; Jacques Y; Béchard D; Cassard L; Chaput N
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32532840
[TBL] [Abstract][Full Text] [Related]
19. Cathepsin C promotes breast cancer lung metastasis by modulating neutrophil infiltration and neutrophil extracellular trap formation.
Xiao Y; Cong M; Li J; He D; Wu Q; Tian P; Wang Y; Yang S; Liang C; Liang Y; Wen J; Liu Y; Luo W; Lv X; He Y; Cheng DD; Zhou T; Zhao W; Zhang P; Zhang X; Xiao Y; Qian Y; Wang H; Gao Q; Yang QC; Yang Q; Hu G
Cancer Cell; 2021 Mar; 39(3):423-437.e7. PubMed ID: 33450198
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary alveolar macrophages contribute to the premetastatic niche by suppressing antitumor T cell responses in the lungs.
Sharma SK; Chintala NK; Vadrevu SK; Patel J; Karbowniczek M; Markiewski MM
J Immunol; 2015 Jun; 194(11):5529-38. PubMed ID: 25911761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]